Hedge funds exited U.S. tech and media stocks in the two weeks to February 21 at the fastest pace in six months, according to ...
Barclays downgraded shares of Moderna (NASDAQ:MRNA – Free Report) from an overweight rating to an equal weight rating in a report published on Tuesday, Ratings reports. The firm currently has $45.00 ...
China is starting to see a rebound in M&As as government stimulus measures start to bear fruit and pressure from Donald Trump ...
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
In a report released on February 14, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price ...
CSL and Cochlear are two of Australia’s blue-chip healthcare stocks, stalwarts of many investors portfolios, whereas Pro ...
Investors, shrugging off ongoing concerns around trade and inflation, are searching for the next catalyst to send stocks ...
Investors seeking to outperform the market should focus their stock-picking efforts on volatile names in the consumer ...
Please be advised, today's conference is being recorded. I would now like to hand the conference over to your speaker today, Lavina Talukdar. Please go ahead. Thank you, Kevin. Good morning, everyone, ...
Moderna Inc. recorded another quarterly loss as vaccine sales wane and the company had an unexpected charge for canceled ...
Hedge fund giant Bridgewater Associates placed a new bet on EV maker Tesla Inc. late last year, as it exited memory chip maker Micron Technology and banking giant Goldman Sachs. The latest 13-F filing ...
Shares of Roku Inc (NASDAQ:ROKU) are up 14.5% in premarket trading, after the streaming giant shared smaller-than-expected ...